Premium
Revolution Medicines Inc (RVMD)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include R... Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.97 | -4.5507045507 | 43.29 | 44.015 | 40.835 | 1050320 | 41.79446279 | CS |
| 4 | 0.97 | 2.40396530359 | 40.35 | 44.68 | 39.36 | 1273080 | 41.77534925 | CS |
| 12 | -15.74 | -27.5849982475 | 57.06 | 59.72 | 39.36 | 1568023 | 45.31049985 | CS |
| 26 | -1.6 | -3.72786579683 | 42.92 | 62.4 | 39.36 | 1328593 | 47.3226342 | CS |
| 52 | 11.83 | 40.1152933198 | 29.49 | 62.4 | 28.43 | 1407589 | 42.24605174 | CS |
| 156 | 19.91 | 92.993928071 | 21.41 | 62.4 | 14.08 | 1272064 | 30.90910372 | CS |
| 260 | 11.97 | 40.7836456559 | 29.35 | 62.4 | 14.08 | 953491 | 31.33197417 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
